Merck Animal Health
Tagged: Merck Animal Health
News (3)
NewsAnimal Health
Merck Animal Health launches Nobivac NXT rabies vaccines for dogs and cats in the US
The non-adjuvanted vaccines offer one-year or three-year protection in a 0.5 mL dose for healthy dogs and cats from 12 weeks of age.
eFeedLink Newsdesk5 Nov 2026
NewsAnimal Health
US FDA authorises Merck's Bravecto Chews for emergency use against New World screwworm in dogs
The emergency use authorisation follows a field study in naturally infested dogs, with EUA-labelled product due to reach US veterinarians by early Q2 2027.
eFeedLink Newsdesk5 Nov 2026
NewsAnimal Health
Merck Animal Health publishes gilvetmab data for canine melanoma and mast cell tumours
Two peer-reviewed studies of the caninised anti-PD-1 antibody report a 66.7% overall clinical benefit rate in dogs with melanoma or mast cell tumours.
eFeedLink Newsdesk11 Oct 2026